A case study showing how the PSR and Ergomed team successfully crossed borders and language barriers allowing a patient based in the Canary Islands to have access to treatment for an ultra-rare disease.
A phase II/III study in Primary Hyperoxaluria (PH) with
– 24 patients with PH, children (>4 years) and adults
– 9 study sites (UK, Germany, Spain, Belgium, USA, Tunisia)
– Full services provided by PSR
Read further to learn more about Ergomed/PSR’s individualized approach to the patient …